# Kappa Opioid Receptor Imaging in Post-traumatic Stress Disorder (PTSD)

> **NCT02237703** · — · TERMINATED · sponsor: **NYU Langone Health** · enrollment: 17 (actual)

## Conditions studied

- Post-traumatic Stress Disorder (PTSD)
- Trauma

## Interventions

- **OTHER:** Positron emission tomography (PET) imaging

## Key facts

- **NCT ID:** NCT02237703
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-03
- **Primary completion:** 2015-03
- **Final completion:** 2016-08
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** The original PI, Alexander Neumeister, left NYULMC. No data was analyzed.
- **Last updated:** 2017-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02237703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02237703, "Kappa Opioid Receptor Imaging in Post-traumatic Stress Disorder (PTSD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02237703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*